TNFRSF9 and neoplasm: A cold tumor can be converted to a “hot tumor” by cisplatin-based chemotherapy, radiotherapy, DC activators (such as agonist CD40 antibodies), and T-cell agonists (such as OX40 or CD137 antibodies) [47,48].